Accessibility settings

This paper is in the following e-collection/theme issue:

Usability of Virtual Reality Simulations (124) Extended Reality, Virtual Reality and Virtual Worlds (1171) Depression and Mood Disorders; Suicide Prevention (2543) Attention Deficit Disorder (ADD/ADHD) (159) Diagnostic Tools in Mental Health (461)

Published on in Vol 13 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/85351, first published .
Computer screen showing an email with text about software and pricing, plus a SPAM filter.

Multimodal Virtual Reality Assessment of Medication Effects in Attention-Deficit/Hyperactivity Disorder and Its Distinction From Depression: Cross-Sectional Study

Multimodal Virtual Reality Assessment of Medication Effects in Attention-Deficit/Hyperactivity Disorder and Its Distinction From Depression: Cross-Sectional Study

Authors of this article:

Laura Asché1 Author Orcid Image ;   Julian Pakos1 Author Orcid Image ;   Hannah Schrage1 Author Orcid Image ;   Johanna Schuder1 Author Orcid Image ;   Luisa Jung1 Author Orcid Image ;   Dario Sanchez1 Author Orcid Image ;   Benjamin Selaskowski1 Author Orcid Image ;   Annika Wiebe1 Author Orcid Image ;   Alexandra Philipsen1 Author Orcid Image ;   Niclas Braun1 Author Orcid Image
Article Authors Cited by (1) Tweetations (1) Metrics

Journals

  1. Pakos J, Asché L, Jung L, Schuder J, Schrage H, Heine C, Popova A, Sanchez D, Wiebe A, Aslan B, Philipsen A, Braun N. Virtual reality (bio-)markers differentiate ADHD from depression and controls. European Archives of Psychiatry and Clinical Neuroscience 2026 View